PL3590542T3 - Peptydy znakowane radionuklidem emitującym pozytony do obrazowania upar metodą pet u ludzi - Google Patents
Peptydy znakowane radionuklidem emitującym pozytony do obrazowania upar metodą pet u ludziInfo
- Publication number
- PL3590542T3 PL3590542T3 PL19193807.5T PL19193807T PL3590542T3 PL 3590542 T3 PL3590542 T3 PL 3590542T3 PL 19193807 T PL19193807 T PL 19193807T PL 3590542 T3 PL3590542 T3 PL 3590542T3
- Authority
- PL
- Poland
- Prior art keywords
- pet imaging
- positron emitting
- labeled peptides
- emitting radionuclide
- human upar
- Prior art date
Links
- 238000003384 imaging method Methods 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201270751 | 2012-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3590542T3 true PL3590542T3 (pl) | 2024-05-13 |
Family
ID=50882823
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13860317T PL2928505T3 (pl) | 2012-12-03 | 2013-11-29 | Peptydy znakowane radionuklidem emitującym pozyton do obrazowania pet upar u ludzi |
| PL19193807.5T PL3590542T3 (pl) | 2012-12-03 | 2013-11-29 | Peptydy znakowane radionuklidem emitującym pozytony do obrazowania upar metodą pet u ludzi |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13860317T PL2928505T3 (pl) | 2012-12-03 | 2013-11-29 | Peptydy znakowane radionuklidem emitującym pozyton do obrazowania pet upar u ludzi |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US9884131B2 (pl) |
| EP (2) | EP2928505B1 (pl) |
| CA (3) | CA3221851A1 (pl) |
| DK (1) | DK2928505T3 (pl) |
| ES (2) | ES2755804T3 (pl) |
| HU (1) | HUE046326T2 (pl) |
| PL (2) | PL2928505T3 (pl) |
| WO (1) | WO2014086364A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10994032B2 (en) * | 2012-05-08 | 2021-05-04 | Trt Innovations Aps | 177-Lu labeled peptide for site-specific uPAR-targeting |
| EP2928505B1 (en) * | 2012-12-03 | 2019-08-28 | Curasight APS | Positron emitting radionuclide labeled peptides for human upar pet imaging |
| CN104725473B (zh) * | 2014-09-11 | 2018-03-20 | 厦门大学附属第一医院 | 一种[18F]AlF标记的PET多肽探针及其制备方法 |
| EP3733215A1 (en) | 2014-09-17 | 2020-11-04 | Fluoguide A/S | Upar targeting peptide for use in peroperative optical imaging of invasive cancer |
| EP3224277B1 (en) | 2014-11-25 | 2020-08-26 | Bristol-Myers Squibb Company | Novel pd-l1 binding polypeptides for imaging |
| CN107207379B (zh) | 2014-11-25 | 2021-08-10 | 百时美施贵宝公司 | 用于生物制品的18f-放射性标记的方法和组合物 |
| US10994033B2 (en) | 2016-06-01 | 2021-05-04 | Bristol-Myers Squibb Company | Imaging methods using 18F-radiolabeled biologics |
| KR102397783B1 (ko) | 2016-06-01 | 2022-05-12 | 브리스톨-마이어스 스큅 컴퍼니 | Pd-l1 결합 폴리펩티드에 의한 pet 영상화 |
| US11987629B2 (en) | 2018-06-01 | 2024-05-21 | Tayu Huaxia Biotech Medical Group Co., Ltd. | Compositions and uses thereof for treating disease or condition |
| CN109285142B (zh) * | 2018-08-07 | 2023-01-06 | 广州智能装备研究院有限公司 | 一种头颈部肿瘤检测方法、装置及计算机可读存储介质 |
| CA3239551A1 (en) | 2021-11-30 | 2023-06-08 | Curasight Aps | Urokinase-type plasminogen activator receptor (upar)-pet/ct in head and neck squamous cell carcinomas (hnsccs) |
| EP4197561A1 (en) | 2021-12-15 | 2023-06-21 | Curasight A/S | Urokinase-type plasminogen activator receptor (upar)-pet/ct in neuroendocrine neoplams |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995025223A1 (en) | 1994-03-11 | 1995-09-21 | Wilson Greatbatch Ltd. | Low power electromagnetic pump |
| US5942492A (en) | 1996-11-12 | 1999-08-24 | Angstrom Pharmaceuticals, Inc. | Cyclic peptides that bind to urokinase-type plasminogen activator receptor |
| US6277818B1 (en) | 1998-10-29 | 2001-08-21 | Angstrom Pharmaceuticals, Inc. | Cyclic peptide ligands that target urokinase plasminogen activator receptor |
| AR020101A1 (es) | 1998-07-01 | 2002-04-10 | Cancerforskingsfonden Af 1989 | Un antagonista peptido del receptor de uroquinasa humana, composicion farmaceutica que lo contiene, su uso para la manufactura de un medicamento y metodopara seleccionar un antagonista peptido adecuado. |
| AU780730B2 (en) | 1999-10-01 | 2005-04-14 | Angstrom Pharmaceuticals, Inc. | Diagnostic probes and therapeutics targeting uPA and uPAR |
| US6896870B1 (en) * | 1999-10-01 | 2005-05-24 | Angstrom Pharmaceuticals, Inc. | Diagnostic probes and therapeutics targeting uPA and uPAR |
| CN101065152A (zh) | 2004-09-29 | 2007-10-31 | 通用电气医疗集团股份有限公司 | 靶向尿激酶纤溶酶原激活物受体的造影剂 |
| EP2056886A2 (en) * | 2006-08-28 | 2009-05-13 | GE Healthcare Limited | 68ga-labeled peptide-based radiopharmaceuticals |
| HUE044625T2 (hu) * | 2011-08-31 | 2019-11-28 | Somscan Aps | PET nyomjelzõ neuroendokrin tumorok képalkotásához |
| CN102600489A (zh) | 2012-02-24 | 2012-07-25 | 南方医科大学南方医院 | 含iRGD序列的多肽放射性药物 |
| US10994032B2 (en) * | 2012-05-08 | 2021-05-04 | Trt Innovations Aps | 177-Lu labeled peptide for site-specific uPAR-targeting |
| EP2928505B1 (en) * | 2012-12-03 | 2019-08-28 | Curasight APS | Positron emitting radionuclide labeled peptides for human upar pet imaging |
| EP3733215A1 (en) * | 2014-09-17 | 2020-11-04 | Fluoguide A/S | Upar targeting peptide for use in peroperative optical imaging of invasive cancer |
-
2013
- 2013-11-29 EP EP13860317.0A patent/EP2928505B1/en active Active
- 2013-11-29 DK DK13860317T patent/DK2928505T3/da active
- 2013-11-29 HU HUE13860317A patent/HUE046326T2/hu unknown
- 2013-11-29 US US14/649,113 patent/US9884131B2/en active Active
- 2013-11-29 WO PCT/DK2013/050402 patent/WO2014086364A1/en active Application Filing
- 2013-11-29 PL PL13860317T patent/PL2928505T3/pl unknown
- 2013-11-29 CA CA3221851A patent/CA3221851A1/en active Pending
- 2013-11-29 PL PL19193807.5T patent/PL3590542T3/pl unknown
- 2013-11-29 EP EP19193807.5A patent/EP3590542B1/en active Active
- 2013-11-29 ES ES13860317T patent/ES2755804T3/es active Active
- 2013-11-29 CA CA2903261A patent/CA2903261C/en active Active
- 2013-11-29 ES ES19193807T patent/ES2972124T3/es active Active
- 2013-11-29 CA CA3106713A patent/CA3106713C/en active Active
-
2017
- 2017-12-05 US US15/832,371 patent/US20180193495A1/en not_active Abandoned
-
2020
- 2020-05-08 US US16/870,776 patent/US11311637B2/en active Active
-
2022
- 2022-03-17 US US17/697,485 patent/US20220202966A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2903261A1 (en) | 2014-06-12 |
| US11311637B2 (en) | 2022-04-26 |
| EP2928505B1 (en) | 2019-08-28 |
| CA3106713A1 (en) | 2014-06-12 |
| ES2972124T3 (es) | 2024-06-11 |
| EP3590542B1 (en) | 2024-01-03 |
| EP2928505A4 (en) | 2016-08-24 |
| CA3221851A1 (en) | 2014-06-12 |
| PL2928505T3 (pl) | 2020-02-28 |
| US20180193495A1 (en) | 2018-07-12 |
| HUE046326T2 (hu) | 2020-03-30 |
| US20160263260A1 (en) | 2016-09-15 |
| EP3590542C0 (en) | 2024-01-03 |
| US20220202966A1 (en) | 2022-06-30 |
| US9884131B2 (en) | 2018-02-06 |
| EP3590542A1 (en) | 2020-01-08 |
| WO2014086364A1 (en) | 2014-06-12 |
| CA2903261C (en) | 2021-03-09 |
| US20200268914A1 (en) | 2020-08-27 |
| ES2755804T3 (es) | 2020-04-23 |
| DK2928505T3 (da) | 2019-11-25 |
| EP2928505A1 (en) | 2015-10-14 |
| CA3106713C (en) | 2024-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE046326T2 (hu) | Pozitront emittáló radionukliddal jelölt peptidek humán uPAR PET-tel történõ leképezésére | |
| IL261259B (en) | Compounds for positron emission tomography | |
| HK1243427A1 (zh) | 治療肽 | |
| IL245744A0 (en) | Therapeutic peptides | |
| HK1219983A1 (zh) | 治療性肽 | |
| HK1197192A1 (en) | Fluorine-18 and carbon-11 labeled radioligands for positron emission tomography (pet) imaging for lrrk2 lrrk2 (pet)-18 -11 | |
| EP2877835A4 (en) | AGILE'S IMAGING SYSTEM | |
| HK1214829A1 (zh) | 治療肽 | |
| EP2739210A4 (en) | RADIATION IMAGING SYSTEM | |
| EP2856928A4 (en) | IMAGING SYSTEM | |
| EP2716224A4 (en) | RADIOGRAPHY SYSTEM | |
| EP2845039A4 (en) | TOTAL MICRO IMPEDANCE IMAGING OF TENSEUR | |
| EP2807180A4 (en) | PEPTIDE AGENTS USED IN ANTICANCER THERAPY | |
| EP2879154A4 (en) | DIGITAL X-RAY SOURCE | |
| SI2970345T1 (sl) | 18F-označena PSMA-ciljana sredstva za pet slikanje | |
| GB201020314D0 (en) | Apoptosis pet imaging agents | |
| EP2735261A4 (en) | IMAGING SYSTEM | |
| PT2851085T (pt) | Composição proteica esterilizada por radiação | |
| EP2826068A4 (en) | X-MATRIX DISPLAY | |
| EP2687147A4 (en) | IMAGING SYSTEM | |
| PL2710988T3 (pl) | Wkładka do butów | |
| GB201420171D0 (en) | Brachytheraphy system & in vivo dose detector therefor | |
| GB201205778D0 (en) | Positron emission detection and imaging | |
| EP2712539A4 (en) | IMAGING SYSTEM | |
| GB201116733D0 (en) | Peptide margin imaging agents |